Kurata, T., Fushida, S., Kinoshita, J., Oyama, K., Yamaguchi, T., Okazaki, M., . . . Ohta, T. (2018). Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil. Cancer Manag Res.
শিকাগো স্টাইলে সাইটেশনKurata, Toru, et al. "Low-dose Eribulin Mesylate Exerts Antitumor Effects in Gastric Cancer By Inhibiting Fibrosis Via the Suppression of Epithelial–mesenchymal Transition and Acts Synergistically With 5-fluorouracil." Cancer Manag Res 2018.
এমএলএ সাইটেশনKurata, Toru, et al. "Low-dose Eribulin Mesylate Exerts Antitumor Effects in Gastric Cancer By Inhibiting Fibrosis Via the Suppression of Epithelial–mesenchymal Transition and Acts Synergistically With 5-fluorouracil." Cancer Manag Res 2018.